TCL Archive Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says August 19, 1994
TCL Archive Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment December 29, 2006
TCL Archive Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit. October 26, 2001
